Skip to main content

Want a detailed portfolio tracker?

Gossamer Bio (GOSS) P/E (2019 - 2026)

Gossamer Bio (GOSS) P/E from Apr 1, 2019 to Jul 20, 2026. The TTM Gossamer Bio (GOSS) P/E is -0.18. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Gossamer Bio (GOSS)

YearP/EChange
2026-0.18-95.67%
2025-4.19+15.47%
2024-3.63+586.95%
2023-0.53-30.28%
2022-0.76-79.14%
2021-3.63+30.31%
2020-2.79-47.22%
2019-5.28N/A

Comparison Gossamer Bio (GOSS) P/E with competitors

Gossamer Bio (GOSS) P/E is -0.18.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.94%
NBYStablecoin Development Corp0.00-102.37%
ENLVEnlivex Ltd0.07-141.26%
FGENFibroGen Inc0.24-232.41%
CHRSCoherus Biosciences Inc0.85-568.05%
FBIOFortress Biotech Inc0.95-623.49%
ORMPOramed Pharmaceuticals Inc1.50-929.09%
AGENAgenus Inc3.01-1760.11%
INVAInnoviva Inc3.15-1839.76%
VXRTVaxart Inc3.55-2058.04%
CRMDCorMedix Inc3.63-2101.45%
CVACCureVac N.V.4.45-2552.24%
GLPGGalapagos NV4.86-2780.17%
SRPTSarepta Therapeutics Inc4.88-2792.97%
ABEOAbeona Therapeutics Inc5.39-3071.76%
ABUSArbutus Biopharma Corp5.60-3186.55%
ZVRAZevra Therapeutics Inc5.89-3347.41%
SPROSpero Therapeutics Inc6.23-3535.62%
CGENCompugen Ltd6.31-3582.78%
RIGLRigel Pharmaceuticals6.87-3890.65%
SLXNSilexion Therapeutics Corp7.30-4124.53%
OMEROmeros Corporation9.26-5207.15%
AUPHAurinia Pharmaceuticals Inc9.58-5387.09%
PLXProtalix BioTherapeutics Inc10.89-6107.51%
ACADAcadia Pharmaceuticals Inc11.73-6569.49%
TBPHTheravance Biopharma Inc12.26-6863.84%
ADMAAdma Biologics Inc12.42-6949.89%
HRMYHarmony Biosciences Holdings Inc13.82-7723.27%
SABSSAB Biotherapeutics Inc14.14-7897.58%
NAGENiagen Bioscience Inc14.82-8273.73%
INCYIncyte Corp15.82-8827.78%
REGNRegeneron Pharmaceuticals Inc15.86-8846.59%
PBYIPuma Biotechnology Inc17.32-9651.41%
CPRXCatalyst Pharmaceuticals Inc17.44-9719.59%
EXELExelixis Inc17.54-9774.04%
TGTXTG Therapeutics Inc18.97-10561.76%
MDXGMimedx Group Inc20.55-11436.85%
XOMAXOMA Royalty Corp22.87-12718.11%
ARGXArgen X SE24.30-13503.23%
CTMXCytomX Therapeutics Inc24.82-13791.79%
XOMAOXOMA Royalty Corp25.34-14080.67%
HALOHalozyme Therapeutics Inc25.62-14234.52%
XOMAPXOMA Royalty Corp25.67-14260.12%
VRTXVertex Pharmaceuticals Inc27.99-15542.42%
RPRXRoyalty Pharma plc - Class A28.69-15924.58%
SLNOSoleno Therapeutics Inc29.02-16105.41%
ASNDAscendis Pharma A/S30.09-16695.75%
LGNDLigand Pharmaceuticals Inc - Class B37.91-21012.98%
APLSApellis Pharmaceuticals Inc39.02-21624.84%
BMRNBiomarin Pharmaceutical Inc42.21-23384.85%
KRYSKrystal Biotech Inc45.34-25112.31%
ONCBeiGene Ltd69.54-38459.83%
PHARPharming Group N.V.75.03-41485.54%
TECHBio-Techne Corp101.96-56342.19%
VCELVericel Corp109.92-60734.71%
ALNYAlnylam Pharmaceuticals Inc117.96-65171.81%
GMABGenmab140.29-77487.07%
TLXTelix Pharmaceuticals Ltd162.15-89546.61%
CORTCorcept Therapeutics Inc212.86-117516.28%